Company intelligence / Profile preview

AiPing Pharmaceutical

Hauppauge, New York, United Stateslinkedin.com ↗

Ownership: Private
Employees: ~450
Development stage: Commercial

Overview

AiPing Pharmaceutical is a US-based CDMO and generic pharmaceutical manufacturer specializing in oral solid dose forms such as tablets, capsules, soft gels, nutraceuticals, and high-potency compounds. The company offers comprehensive product development, formulation, analytical development, process development, encapsulation, packaging solutions—including bottle filling and blister packaging—and has significant capacity for global supply. No proprietary clinical pipeline or clinical trial results are reported.

Modalities: Small moleculeNutraceuticalsTabletsCapsulesSoft gels
Industry: Contract Manufacturing Organization

Beyond the preview

Go deeper on AiPing Pharmaceutical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on AiPing Pharmaceutical.

Explore the full profile